Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Livongo Health, Inc. (LVGO)
|
Add to portfolio |
|
|
|
| Price: |
$145.40
| | Metrics |
| OS: |
100.3
|
M
| |
-6
|
% ROE
|
| Market cap: |
$14.6
|
B
| |
-12
|
% ROIC
|
|
Net cash:
|
$440
|
M
| |
$4.38
|
per share
|
|
EV:
|
$14.1
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($30.4)
|
M
| |
|
|
|
EBIT
|
($36.2)
|
M
| |
|
|
| EPS |
($0.47)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 170.2 | 68.4 | 30.9 |
| Revenue growth | 148.7% | 121.8% | |
| Cost of goods sold | 46.2 | 20.3 | 8.3 |
| Gross profit | 124.0 | 48.2 | 22.5 |
| Gross margin | 72.9% | 70.4% | 73.1% |
| Sales and marketing | 78.1 | 36.4 | 16.5 |
| Research and development | 49.8 | 24.9 | 12.0 |
| General and administrative | 55.7 | 23.1 | 11.1 |
| EBITA | -58.6 | -33.2 | -17.0 |
| EBITA margin | -34.5% | -48.5% | -55.2% |
| Amortization of intangibles | 2.6 | 0.6 | 0.0 |
| EBIT | -61.2 | -33.8 | -17.0 |
| EBIT margin | -36.0% | -49.4% | -55.2% |
| Pre-tax income | -56.6 | -33.4 | -16.9 |
| Income taxes | -1.4 | 0.0 | -0.1 |
| Tax rate | 2.4% | | 0.4% |
| Net income | -55.4 | -33.5 | -17.0 |
| Net margin | -32.5% | -49.0% | -55.1% |
| |
| Diluted EPS | ($1.09) | ($2.02) | ($1.18) |
| Shares outstanding (diluted) | 50.9 | 16.6 | 14.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|